Crinetics Pharmaceuticals Inc (CRNX)
44.41
-0.96
(-2.12%)
USD |
NASDAQ |
May 31, 16:00
44.45
+0.04
(+0.09%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 3.502B for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 3.502B |
| May 30, 2024 | 3.578B |
| May 29, 2024 | 3.613B |
| May 28, 2024 | 3.695B |
| May 24, 2024 | 3.743B |
| May 23, 2024 | 3.835B |
| May 22, 2024 | 3.986B |
| May 21, 2024 | 3.904B |
| May 20, 2024 | 3.992B |
| May 17, 2024 | 4.053B |
| May 16, 2024 | 4.094B |
| May 15, 2024 | 3.982B |
| May 14, 2024 | 3.894B |
| May 13, 2024 | 3.780B |
| May 10, 2024 | 3.785B |
| May 09, 2024 | 3.897B |
| May 08, 2024 | 4.013B |
| May 07, 2024 | 3.758B |
| May 06, 2024 | 3.667B |
| May 03, 2024 | 3.717B |
| May 02, 2024 | 3.684B |
| May 01, 2024 | 3.547B |
| April 30, 2024 | 3.451B |
| April 29, 2024 | 3.465B |
| April 26, 2024 | 3.317B |
| Date | Value |
|---|---|
| April 25, 2024 | 3.330B |
| April 24, 2024 | 3.411B |
| April 23, 2024 | 3.482B |
| April 22, 2024 | 3.421B |
| April 19, 2024 | 3.384B |
| April 18, 2024 | 3.387B |
| April 17, 2024 | 3.466B |
| April 16, 2024 | 3.425B |
| April 15, 2024 | 3.440B |
| April 12, 2024 | 3.502B |
| April 11, 2024 | 3.772B |
| April 10, 2024 | 3.605B |
| April 09, 2024 | 3.684B |
| April 08, 2024 | 3.647B |
| April 05, 2024 | 3.733B |
| April 04, 2024 | 3.664B |
| April 03, 2024 | 3.740B |
| April 02, 2024 | 3.613B |
| April 01, 2024 | 3.654B |
| March 28, 2024 | 3.648B |
| March 27, 2024 | 3.462B |
| March 26, 2024 | 3.380B |
| March 25, 2024 | 3.360B |
| March 22, 2024 | 3.451B |
| March 21, 2024 | 3.504B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
283.01M
Minimum
Mar 16 2020
4.094B
Maximum
May 16 2024
1.043B
Average
882.31M
Median
May 09 2022
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 1.911B |
| Geron Corp | 2.106B |
| Madrigal Pharmaceuticals Inc | 5.036B |
| PTC Therapeutics Inc | 2.790B |
| Syndax Pharmaceuticals Inc | 1.638B |
Market Cap Related Metrics
| PEG Ratio | -0.7707 |
| Price to Book Value | 4.003 |
| Price | 44.41 |
| Earnings Yield | -8.51% |
| PEGY Ratio | -0.7707 |